Source: BioPortfolio

VaxInnate: VaxInnate Corp Pharmaceuticals Healthcare Deals and Alliances Profile Updated 27022017 Prices from USD $250

SummaryVaxInnate Corp VaxInnate is a biotechnology company that develops and manufactures novel vaccines for pandemic and seasonal influenza. The company offers product pipeline such as pandemic influenza seasonal influenze dengue and clostridium difficile...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Wayne F. Pisano's photo - President & CEO of VaxInnate

President & CEO

Wayne F. Pisano

CEO Approval Rating

67/100

Read more